Carregant...

Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

BACKGROUND: Cerebral vasospasm and delayed cerebral ischemia continue to be major contributors to morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH). PURPOSE: The purpose of this review was to evaluate the pharmacotherapy interventions for the prevention and management of cerebra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hosp Pharm
Autor principal: Kiser, Tyree H.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210716/
https://ncbi.nlm.nih.gov/pubmed/35694374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1310/hpj48S5-S2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!